These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27390019)

  • 1. Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus.
    Zhang D; Mably AJ; Walsh DM; Rowan MJ
    Cereb Cortex; 2017 Jul; 27(7):3724-3735. PubMed ID: 27390019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Based Glutamate Scavengers Reverse Traumatic Brain Injury-Induced Synaptic Plasticity Disruption by Decreasing Glutamate Level in Hippocampus Interstitial Fluid, but Not Cerebral Spinal Fluid, In Vivo.
    Zhang D; Xiao M; Wang L; Jia W
    Neurotox Res; 2019 Feb; 35(2):360-372. PubMed ID: 30255425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.
    Zhang D; Qi Y; Klyubin I; Ondrejcak T; Sarell CJ; Cuello AC; Collinge J; Rowan MJ
    Neuropharmacology; 2017 Jul; 121():231-246. PubMed ID: 28390893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β1-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse.
    Varga E; Juhász G; Bozsó Z; Penke B; Fülöp L; Szegedi V
    J Alzheimers Dis; 2015; 45(2):449-56. PubMed ID: 25547631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
    Klyubin I; Ondrejcak T; Hayes J; Cullen WK; Mably AJ; Walsh DM; Rowan MJ
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130147. PubMed ID: 24298149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Aß.
    Zhang D; Jin B; Ondrejcak T; Rowan MJ
    Hippocampus; 2016 Dec; 26(12):1655-1665. PubMed ID: 27701797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Isoflurane, Tumor Necrosis Factor-α and β-Amyloid on Long-term Potentiation in Rat Hippocampal Slices.
    Zhou R; Bickler P
    Anesth Analg; 2017 Feb; 124(2):582-587. PubMed ID: 28099324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion.
    Marosi M; Fuzik J; Nagy D; Rákos G; Kis Z; Vécsei L; Toldi J; Ruban-Matuzani A; Teichberg VI; Farkas T
    Eur J Pharmacol; 2009 Feb; 604(1-3):51-7. PubMed ID: 19135048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
    Huang S; Tong H; Lei M; Zhou M; Guo W; Li G; Tang X; Li Z; Mo M; Zhang X; Chen X; Cen L; Wei L; Xiao Y; Li K; Huang Q; Yang X; Liu W; Zhang L; Qu S; Li S; Xu P
    Brain Res; 2018 Jan; 1678():129-137. PubMed ID: 29066369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Amyloid triggers aberrant over-scaling of homeostatic synaptic plasticity.
    Gilbert J; Shu S; Yang X; Lu Y; Zhu LQ; Man HY
    Acta Neuropathol Commun; 2016 Dec; 4(1):131. PubMed ID: 27955702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo.
    Hu NW; Klyubin I; Anwyl R; Rowan MJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20504-9. PubMed ID: 19918059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.
    Gault VA; Hölscher C
    J Neurophysiol; 2008 Apr; 99(4):1590-5. PubMed ID: 18234983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Val⁸-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid β peptide in rats.
    Wang XH; Yang W; Hölscher C; Wang ZJ; Cai HY; Li QS; Qi JS
    J Neurosci Res; 2013 Apr; 91(4):568-77. PubMed ID: 23335292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.
    Parameshwaran K; Sims C; Kanju P; Vaithianathan T; Shonesy BC; Dhanasekaran M; Bahr BA; Suppiramaniam V
    Synapse; 2007 Jun; 61(6):367-74. PubMed ID: 17372971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine.
    Klyubin I; Wang Q; Reed MN; Irving EA; Upton N; Hofmeister J; Cleary JP; Anwyl R; Rowan MJ
    Neurobiol Aging; 2011 Apr; 32(4):614-23. PubMed ID: 19446369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
    Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC
    Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
    Huang Y; Shen W; Su J; Cheng B; Li D; Liu G; Zhou WX; Zhang YX
    J Alzheimers Dis; 2017; 57(3):885-897. PubMed ID: 28269783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
    Wu MN; He YX; Guo F; Qi JS
    Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.